FDA approves gene therapy for children with sickle cell disease ages 2+

Дата публикации: 09-07-2026 00:09:35

The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, which a Nashville doctor described as a medical milestone.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies	0	14.59	12-08-2026
2	Vertex Announces FDA Approval for Expanded Use of Casgevy for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	0	9.35	01-07-2026
3	Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes	0	22.68	12-06-2026
4	Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers	0	11.77	17-07-2026
5	A forgotten drug is giving new hope to kids with a rare disease	0	11.52	29-04-2026
6	Gene Therapy Cures Soccer-Loving Boy of Beta Thalassemia	0	24.6	22-06-2026
7	New PILL for psoriasis approved... giving hope to millions suffering from debilitating skin condition	0	5.26	18-03-2026
8	Skyrizi (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease	0	13.95	26-06-2026
9	В РФ поступила первая партия швейцарского препарата для лечения гемофилии с маркировкой	0	0	02-06-2020
10	Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy	0	5	08-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.wkrn.com.